Metafoodx | $9,400,000 | (May 16, 2025)
Ascendx | $110,000,000 | (May 16, 2025)
Algoma | $2,300,000 | (May 16, 2025)
Certified by Founder
Lodge
Indapta Therapeutics
start up
United States
- Seattle & Houston
- 18/12/2024
- Unknown
- $22,500,000
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
- Industry Biotechnology
- Website https://indapta.com/
- LinkedIn https://www.linkedin.com/company/indapta-therapuetics/
Plakar | $3,000,000 | (May 16, 2025)
Solestial, Inc. | $17,000,000 | (May 16, 2025)
Adyton PBC | $11,000,000 | (May 16, 2025)
Sproutr | Undisclosed Amount | (May 16, 2025)
Voltra | $1,800,000 | (May 16, 2025)
IMPRINT(US) | $15,000,000 | (May 16, 2025)
Sprinter Health | $55,000,000 | (May 16, 2025)
CarbonSix | $4,000,000 | (May 16, 2025)
Zeno Power | $50,000,000 | (May 16, 2025)